Showing results (11-20 of 18) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
The Medical Journal of Australia|June 25, 2023
Clinical practice guideline for deprescribing opioid analgesics: summary of recommendationsAili V Langford, Christine Cw Lin, Lisa Bero, et al.Orphanet Journal of Rare Diseases|September 17, 2014
A call for action to improve access to care and treatment for patients with rare diseases in the Asia-Pacific regionSwee-Sung Soon, Gilberto Lopes, Hwee-Yong Lim, et al.The Medical Journal of Australia|May 30, 2021
Developing clinical indicators for oncology: the inaugural cancer care indicator set for the Australian Council on Healthcare StandardsEva Segelov, Christine Carrington, Sanchia Aranda, et al.Journal of Clinical Epidemiology|November 6, 2023
Context matters: using an Evidence to Decision (EtD) framework to develop and encourage uptake of opioid deprescribing guideline recommendations at the point-of-careAili V Langford, Lisa Bero, Chung-Wei Christine Lin, et al.Frontiers in Pharmacology|June 25, 2014
Dabigatran - a continuing exemplar case history demonstrating the need for comprehensive models to optimize the utilization of new drugsBrian Godman, Rickard E Malmström, Eduardo Diogene, et al.Expert Review of Clinical Pharmacology|December 10, 2014
Are new models needed to optimize the utilization of new medicines to sustain healthcare systems?Brian Godman, Rickard E Malmström, Eduardo Diogene, et al.Frontiers in Pharmacology|May 30, 2013
Dabigatran - a case history demonstrating the need for comprehensive approaches to optimize the use of new drugsRickard E Malmström, Brian B Godman, Eduard Diogene, et al.Expert Review of Pharmacoeconomics & Outcomes Research|February 4, 2021
Potential approaches for the pricing of cancer medicines across Europe to enhance the sustainability of healthcare systems and the implicationsBrian Godman, Andrew Hill, Steven Simoens, et al.Pageof 2